
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 949 | 884 | 846 | 1111 | 1129 | 1726 |
Fund Return | -5.06% | -11.59% | -15.43% | 3.56% | 2.46% | 5.61% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FCP MEDICAL BioHealth-Trends EUR | 589.72M | -4.51 | 8.39 | 7.58 | ||
FCP MEDICAL BioHealth Trends I | 589.72M | -4.43 | 8.93 | 8.47 | ||
FCP MEDICAL BioHealth Trends EUR H | 589.72M | -5.11 | 3.32 | 4.87 | ||
FFPB MultiTrend Plus | 228.32M | 3.70 | 3.87 | 2.14 | ||
FFPB Dividenden Select | 71.39M | 6.24 | 4.40 | 3.88 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A EUR H AccE | 63.54B | -1.95 | 10.69 | 6.70 | ||
Invesco JapEqAdvantage C EUR H AccE | 63.54B | -1.82 | 11.66 | 7.54 | ||
LU1841614867 | 266.63M | 0.91 | 11.92 | - | ||
LU1482751903 | 439.28M | 1.06 | 12.91 | - | ||
Morgan Stanley Global Brands CH | 20.2B | 3.42 | 1.88 | 6.04 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Insmed | US4576693075 | 6.17 | 74.04 | +0.46% | |
Crinetics Pharma | US22663K1079 | 5.60 | 35.40 | +3.33% | |
Eli Lilly | US5324571083 | 5.06 | 821.86 | -0.27% | |
Vertex | US92532F1003 | 3.86 | 495.42 | +1.45% | |
UCB | BE0003739530 | 3.71 | 181.00 | +6.88% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review